Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001284456 | SCV001470262 | uncertain significance | not provided | 2020-08-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035523 | SCV005032046 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-09-25 | criteria provided, single submitter | clinical testing | The p.W3191S variant (also known as c.9572G>C), located in coding exon 25 of the BRCA2 gene, results from a G to C substitution at nucleotide position 9572. The tryptophan at codon 3191 is replaced by serine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |